CN116056715A - 血液净化浓缩物 - Google Patents

血液净化浓缩物 Download PDF

Info

Publication number
CN116056715A
CN116056715A CN202180032037.0A CN202180032037A CN116056715A CN 116056715 A CN116056715 A CN 116056715A CN 202180032037 A CN202180032037 A CN 202180032037A CN 116056715 A CN116056715 A CN 116056715A
Authority
CN
China
Prior art keywords
acid
mmol
blood purification
preparation
purification concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180032037.0A
Other languages
English (en)
Inventor
冯克民
夏永彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN116056715A publication Critical patent/CN116056715A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种无醋酸血液净化浓缩物，为固体或液体制剂，其中的酸碱调节剂为富马酸或马来酸、琥珀酸中的一种或两种及三种与柠檬酸的混合物。

Description

PCT国内申请，说明书已公开。

Claims (9)

  1. PCT国内申请，权利要求书已公开。
CN202180032037.0A 2020-05-08 2021-05-07 血液净化浓缩物 Pending CN116056715A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010390598.5A CN111603479A (zh) 2020-05-08 2020-05-08 血液净化浓缩物
CN2020103905985 2020-05-08
PCT/CN2021/092064 WO2021223732A1 (zh) 2020-05-08 2021-05-07 血液净化浓缩物

Publications (1)

Publication Number Publication Date
CN116056715A true CN116056715A (zh) 2023-05-02

Family

ID=72196450

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010390598.5A Withdrawn CN111603479A (zh) 2020-05-08 2020-05-08 血液净化浓缩物
CN202180032037.0A Pending CN116056715A (zh) 2020-05-08 2021-05-07 血液净化浓缩物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202010390598.5A Withdrawn CN111603479A (zh) 2020-05-08 2020-05-08 血液净化浓缩物

Country Status (2)

Country Link
CN (2) CN111603479A (zh)
WO (1) WO2021223732A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111603479A (zh) * 2020-05-08 2020-09-01 夏永彪 血液净化浓缩物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1938058A (zh) * 2004-03-30 2007-03-28 尼普洛株式会社 透析用固体制剂
CN101084878A (zh) * 2006-06-09 2007-12-12 桂保松 一种含枸橼酸血液透析液干粉
CN101366710A (zh) * 2007-08-16 2009-02-18 北京信东联创生物技术有限公司 用于血液过滤术或血液透析术之医药组合物
CN108066356A (zh) * 2018-02-05 2018-05-25 济泰（上海）生物科技有限公司 一种血液透析浓缩物
CN111603479A (zh) * 2020-05-08 2020-09-01 夏永彪 血液净化浓缩物

Also Published As

Publication number Publication date
WO2021223732A1 (zh) 2021-11-11
CN111603479A (zh) 2020-09-01

Similar Documents

Publication Publication Date Title
TWI326597B (en) Bicarbonate-based solutions for dialysis therapies
Fassler et al. Magnesium toxicity as a cause of hypotension and hypoventilation: occurrence in patients with normal renal function
AU754537B2 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
CN101209344B (zh) 高渗液组合物在制备促进伤口愈合的药物中的应用
AU664492B2 (en) Method and composition for treating inflammatory bowel disorders
CN116056715A (zh) 血液净化浓缩物
CN115811988A (zh) 一种血液净化分子浓缩物及其制备方法与应用
JP6425661B2 (ja) 透析組成物
CN101756949A (zh) 一种盐酸氨溴索与半胱氨酸的组合物及其制备方法
Schreiner et al. The patient with chronic renal failure and surgery
Lee et al. Severe glyphosate-surfactant intoxication: successful treatment with continuous renal replacement therapy
CN103638526B (zh) 一种血液净化用制剂及其制备方法与应用
CN111821532A (zh) 一种置换液配方的精准调钠方法
WO2009100591A1 (zh) 一定浓度的盐酸水在治疗血管疾病中的应用
CN107281098A (zh) 一种血液滤过置换液
CN101579307A (zh) 高渗注射剂在制备促进伤口愈合药物中的用途
RU2699967C1 (ru) Способ комплексного лечения энтеральной недостаточности у детей с тяжелой термической травмой
RU2468760C1 (ru) Способ лечения абдоминального сепсиса желчного происхождения, осложненного коагулопатией
RU2461394C2 (ru) Способ лечения гнойно-воспалительных осложнений у онкоурологических больных
Guo et al. Analysis of the extracorporeal anticoagulation effect of modified citrate infusion during continuous haemodialysis in critically ill patients
CN117919274A (zh) 一种血液透析浓缩物
CN117100905A (zh) 促进伤口愈合的敷料
CN114848655A (zh) 一种含有机磷酸盐血液过滤置换液的制备方法及应用
RU2475234C2 (ru) Способ профилактики тяжелых осложнений при хирургическом лечении массивных и субмассивных кровопотерь с продолжающимся кровотечением
RU1796193C (ru) Способ лечени острой печеночно-почечной недостаточности

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication